Quantbot Technologies LP Chinook Therapeutics, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$12.59 - $18.8 $43,699 - $65,254	3,471 New	3,471 $60,000
Q1 2022 May 16, 2022	SELL	$12.02 - $16.69 $60,100 - $83,450	-5,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$10.69 - $16.83 $28,863 - $45,440	2,700 Added 117.39%	5,000 $81,000
Q3 2021 Nov 09, 2021	BUY	$11.5 - $14.86 $26,450 - $34,178	2,300 New	2,300 $29,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.